Case Report  |   March 2020
Platelet-Rich Plasma and Epidural Platelet Lysate: Novel Treatment for Lumbar Disk Herniation
Author Notes
  • Financial Disclosures: None reported. 
  • Support: None reported. 
  •  *Address correspondence to Benjamin Rawson, DO, Center for Healing and Regenerative Medicine, 10815 Ranch Rd 2222, Bldg 3B, Ste 200, Austin, TX 78730-1178. Email: rawson.rehab@gmail.com
     
Article Information
Neuromusculoskeletal Disorders / Pain Management/Palliative Care / Low Back Pain
Case Report   |   March 2020
Platelet-Rich Plasma and Epidural Platelet Lysate: Novel Treatment for Lumbar Disk Herniation
The Journal of the American Osteopathic Association, March 2020, Vol. 120, 201-207. doi:https://doi.org/10.7556/jaoa.2020.032
The Journal of the American Osteopathic Association, March 2020, Vol. 120, 201-207. doi:https://doi.org/10.7556/jaoa.2020.032
Abstract

Lumbar herniated disks present a common cause of significant axial low back and radiating leg pain. This situation poses a risk for potentially permanent neurologic compromise, including numbness, weakness, and bowel and bladder dysfunction. Traditional treatment strategies such as medications, epidural steroids, and surgery all carry potential risk for iatrogenic sequelae. Platelet-rich plasma can be processed to isolate and concentrate the growth factors contained in platelet α granules. This solution is then referred to as platelet lysate. Lumbar injection of platelet-rich plasma along with epidural injection of platelet lysate is a novel therapeutic option that can initiate or expedite the resorption of herniated lumbar disk material, which can facilitate the decompression of the affected spinal structures. This process is thought to occur through a complex interplay of cytokines and growth factors that facilitate neovascularization along with macrophage-induced phagocytosis of the disk material. In the present report, we describe 2 patients with symptomatic herniated disks who were successfully treated with epidural injection of growth factors derived from concentrated platelet lysate.

Subscribe to view more

For full access to this article, log in to an existing user account, purchase an annual subscription, or purchase a short-term subscription.

Order a subscription

Subscribe

Pay Per View

Entire Journal
30-Day Access

$50.00

Buy Now

This Issue
7-Day Access

$25.00

Buy Now

This article
24-Hour Access

$10.00

Buy Now

Sign In Or Create an account

Please sign in using your Osteopathic.org login.
If you do not have an AOA login, you may create a new account.

Or Subscribe